A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis

BACKGROUND: Standard treatment for patients with erosive esophagitis (EE) is proton-pump inhibitors (PPIs), but some patients are resistant to PPIs. We aimed to evaluate the acid-inhibitory effects and efficacy of a novel potassium-competitive acid blocker (vonoprazan) in patients with PPI-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwakiri, Katsuhiko, Sakurai, Yuuichi, Shiino, Madoka, Okamoto, Hiroyuki, Kudou, Kentaro, Nishimura, Akira, Hiramatsu, Naoki, Umegaki, Eiji, Ashida, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424876/
https://www.ncbi.nlm.nih.gov/pubmed/28567114
http://dx.doi.org/10.1177/1756283X17705329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424876/
https://www.ncbi.nlm.nih.gov/pubmed/28567114
http://dx.doi.org/10.1177/1756283X17705329

Ejemplares similares